相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors
Sonali Sharma et al.
BLOOD (2021)
Integration of T helper and BCR signals governs enhanced plasma cell differentiation of memory B cells by regulation of CD45 phosphatase activity
Peter Szodoray et al.
CELL REPORTS (2021)
T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?
Philipp M. Roessner et al.
LEUKEMIA (2020)
A Chemo-enzymatically Linked Bispecific Antibody Retargets T Cells to a Sialylated Epitope on CD43 in Acute Myeloid Leukemia
Lina Bartels et al.
CANCER RESEARCH (2019)
Galectin-1 promotes hepatocellular carcinoma and the combined therapeutic effect of OTX008 galectin-1 inhibitor and sorafenib in tumor cells
Zoe Leung et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans
N. Giovannone et al.
NATURE COMMUNICATIONS (2018)
Galectin-9 binds IgM-BCR to regulate B cell signaling
Anh Cao et al.
NATURE COMMUNICATIONS (2018)
Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Cirino Botta et al.
BLOOD (2018)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes
Maria Elena Bravo-Adame et al.
IMMUNOLOGY (2017)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Galectin-1 Inhibitor OTX008 Induces Tumor Vessel Normalization and Tumor Growth Inhibition in Human Head and Neck Squamous Cell Carcinoma Models
Nathan A. Koonce et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood
T. M. Herndon et al.
LEUKEMIA (2017)
Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition
E. Slinger et al.
LEUKEMIA (2017)
Engagement of distinct epitopes on CD43 induces different co-stimulatory pathways in human T cells
Madhura Modak et al.
IMMUNOLOGY (2016)
T-helper signals restore B-cell receptor signaling in autoreactive anergic B cells by upregulating CD45 phosphatase activity
Peter Szodoray et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Mechanisms of PD-L1/PD-1-mediated CD8 T-cell dysfunction in the context of aging-related immune defects in the Eμ-TCL1 CLL mouse model
Fabienne McClanahan et al.
BLOOD (2015)
Novel role for galectin-1 in T-cells under physiological and pathological conditions
Magdolna Deak et al.
IMMUNOBIOLOGY (2015)
Chronic Lymphocytic Leukemia Cells Express CD38 in Response to Th1 Cell-Derived IFN-γ by a T-bet-Dependent Mechanism
Simone Burgler et al.
JOURNAL OF IMMUNOLOGY (2015)
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis
Lucile Astorgues-Xerri et al.
EUROPEAN JOURNAL OF CANCER (2014)
The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy
Graham Packham et al.
HAEMATOLOGICA (2014)
Galectin-1 serum levels reflect tumor burden and adverse clinical features in classical Hodgkin lymphoma
Jing Ouyang et al.
BLOOD (2013)
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
Davide Brusa et al.
HAEMATOLOGICA (2013)
Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1
D. O. Croci et al.
LEUKEMIA (2013)
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
B cell receptor signaling in chronic lymphocytic leukemia
Jan A. Burger et al.
TRENDS IN IMMUNOLOGY (2013)
Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia
P. Oppezzo et al.
BLOOD CANCER JOURNAL (2013)
Chronic Lymphocytic Leukemia Cells Are Activated and Proliferate in Response to Specific T Helper Cells
Audun Os et al.
CELL REPORTS (2013)
Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death
Mary C. Clark et al.
BLOOD (2012)
Antitumor Agent Calixarene 0118 Targets Human Galectin-1 as an Allosteric Inhibitor of Carbohydrate Binding
Ruud P. M. Dings et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45
Stephanie M. Stanford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells
Carlo Calissano et al.
MOLECULAR MEDICINE (2011)
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells
E. Tibaldi et al.
LEUKEMIA (2011)
Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia
Jan A. Burger
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
N- and O-Glycans Modulate Galectin-1 Binding, CD45 Signaling, and T Cell Death
Lesley A. Earl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Relevance of the Immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
Katherine I. Lin et al.
BLOOD (2009)
CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells
Michelle L. Hermiston et al.
IMMUNOLOGICAL REVIEWS (2009)
Galectin-1 Co-clusters CD43/CD45 on Dendritic Cells and Induces Cell Activation and Migration through Syk and Protein Kinase C Signaling
Jennifer A. Fulcher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment
Piers E. M. Patten et al.
BLOOD (2008)
Galectin-1 supports the survival of CD45RA(-) primary myeloma cells in vitro
Saeid Abroun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Tumor-derived IL-6 may contribute to the immunological defect in CLL
A. G. S. Buggins et al.
LEUKEMIA (2008)
The AP1-dependent secretion of galectin-1 by Reed - Sternberg cells fosters immune privilege in classical Hodgkin lymphoma
Przemyslaw Juszczynski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death
Marta A. Toscano et al.
NATURE IMMUNOLOGY (2007)
Galectin-1:: a key effector of regulation mediated by CD4+CD25+ T cells
Marina I. Garin et al.
BLOOD (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Galectin-1: a small protein with major functions
Isabelle Camby et al.
GLYCOBIOLOGY (2006)
Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death
Joseph D. Hernandez et al.
JOURNAL OF IMMUNOLOGY (2006)
Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death
BN Stillman et al.
JOURNAL OF IMMUNOLOGY (2006)
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
G Görgün et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Cell surface CD43 determination improves diagnostic precision in late B-cell diseases
G Jung et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
T type 1/type 2 subsets balance in B-cell chronic lymphocytic leukemia - the three-color flow cytometry analysis
M Podhorecka et al.
LEUKEMIA RESEARCH (2002)
Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell lines
R Fajka-Boja et al.
IMMUNOLOGY LETTERS (2002)
Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL)
ED Rossmann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
CD45 modulates galectin-1-induced T cell death:: Regulation by expression of core 2 O-glycans
JT Nguyen et al.
JOURNAL OF IMMUNOLOGY (2001)
Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells
M Fouillit et al.
GLYCOBIOLOGY (2000)
Cutting edge: CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death
KE Pace et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
